McEwen to acquire ~31% stake in Paragon Geochemical (PhotonAssay) for CAD $15.3M in stock

McEwen Inc.

McEwen to acquire 648,002 shares from Britannia Life Sciences and 226,286 shares via private placement at CAD $17.50/share.
Total consideration CAD $15.3 million, payable in McEwen common shares; McEwen becomes largest shareholder.
VP Ian Ball to join Paragon board upon listing; MUX gets right to nominate one additional board member.
Paragon operates 3 labs, plans 8 more; PhotonAssay technology used for precious/base metals assaying.
McEwen currently uses PhotonAssay at Fox Complex (Ontario) and Gold Bar Mine (Nevada) for faster exploration decisions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.